Peptides

Peptide Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Mal-RSQSRSRYYRQRQRSRRRRRRS-NH2 include the following: Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells X Li , P Stuckert, I Bosch , JD Marks, WA Marasco - Cancer gene therapy, 2001 - nature.comhttps://www.nature.com/articles/7700337 Antibody-Mediated BRCC36 Silencing: A Novel Approach for Targeted Breast Cancer Therapy X Chen - 2010 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA513475 BRCA1-Associated Protein BRCC36: A Novel Target for Breast Cancer Therapy X Chen - 2008 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA520557 Optimizing Protein Purification for RNA-Binding Recombinant Fusion Proteins T Li - 2021 - search.proquest.comhttps://search.proquest.com/openview/9c15570b4764f0513f6ac112d38e0653/1?pq-origsite=gscholar&cbl=18750&diss=y Carrier-free CXCR4-targeted nanoplexes designed for polarizing macrophages to suppress tumor growth MB Deci, M Liu, J Gonya, CJ Lee, T Li - Cellular and Molecular , 2019 - Springerhttps://link.springer.com/article/10.1007/s12195-019-00589-w mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446 GD Bell , Y Yang, E Leung , GW Krissansen - PLoS One, 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0201464

A synthetic peptide for use as a blocking control in assays to test for specificity of CAPN10 antibody, catalog no. 70R-2226

A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-5066

Peptide H-EQEQMISCKFNMTGL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EQEQMISCKFNMTGL-OH include the following: Anti-tumor activity mediated by protein and peptide transduction of HIV viral protein R (Vpr) K Muthumani, VM Lambert, M Shanmugam - Cancer Biology & , 2009 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.4161/cbt.8.2.7205

Peptide H-GSFPWQAK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GSFPWQAK-OH include the following: Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease M Sanda , P Pompach, Z Brnakova , J Wu - Molecular & Cellular , 2013 - ASBMBhttps://www.mcponline.org/article/S1535-9476(20)31112-9/fulltext

Angiotensin I is a protein encoded by the AGTR1 gene. It is a precursor to angiotensin II, which causes vasoconstriction and has other effects on blood vessels, kidneys, and the heart. Angiotensin I is produced by proteolytic cleavage of pro-angiotensinogen in the liver. The mouse monoclonal antibody to human angiotensin I (mAb-HAI) recognizes both human and bovine angiotensin I. This antibody can be used for immunohistochemistry or Western blot analysis of cells from mice that have been injected with mAb-HAI. It has also been shown to reduce kidney fibrosis in mice when it is administered as a subcutaneous injection three times per week. The following product details are for an eCommerce site selling active ingredients:

β-Interleukin II is a peptide with the sequence NH2-ILE-LEU-ASN-GLY-ILE-ASN-ASN-TYR-LYS-ASN-PRO-LYS-LEU-COOH.

A synthetic peptide for use as a blocking control in assays to test for specificity of NDUFS8 antibody, catalog no. 70R-10377

Cholecystokinin, CCK Octapeptide (26-33) is used in the biological studies in the preparation of opioid receptors agonistic and CCK receptor antagonistic activity. It plays a role in satiety. This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

A synthetic peptide for use as a blocking control in assays to test for specificity of FGL2 antibody, catalog no. 70R-4461

Peptide H-GIYDGDLK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-GIYDGDLK^-OH include the following: Quantitative assessment of the contribution of sodium-dependent taurocholate co-transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin Y Bi, X Qiu , CJ Rotter, E Kimoto - & drug disposition, 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/bdd.1861 Absolute measurement of species differences in sodium taurocholate cotransporting polypeptide (NTCP/Ntcp) and its modulation in cultured hepatocytes X Qiu , YA Bi, LM Balogh, Y Lai - Journal of pharmaceutical sciences, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354915309382

Peptide H-FPLTNA^IK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FPLTNA^IK^-OH include the following: Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients MP Stoop, V Singh , C Stingl, R Martin - Journal of proteome ..., 2013 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr3012107

A synthetic peptide for use as a blocking control in assays to test for specificity of CCPG1 antibody, catalog no. 70R-6269

Peptide H-V^GEFSGANK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-V^GEFSGANK-OH include the following: Chemoproteomic approach for the quantitative identification of arsenic-binding proteins X Dong , P Wang , Y Wang - Chemical research in toxicology, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.chemrestox.2c00244 Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry S Hu , T Yu , Y Xie, Y Yang, Y Li, X Zhou - Cancer Genomics & , 2007 - cgp.iiarjournals.orghttps://cgp.iiarjournals.org/content/4/2/55.short Salivary diagnostics for oral cancer DT Wong - Journal of the California Dental Association, 2006 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/19424396.2006.12222198 Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers aca‰ CsÅ‘sz , P Labiscsak, G Kallo , B Markus , M Emri - PLoS , 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177282

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool

Catalogue peptide; min. 95% purity

Secretin (28-54), human, is a 27-amino acid residue peptide with a C-terminal amidation, acting on human secretin receptors.

Androgen Receptor Antagonist 9 (compound 28) serves as an antagonist to the androgen receptor [1].

Catalogue peptide; min. 95% purity

A synthetic peptide for use as a blocking control in assays to test for specificity of C20orf111 antibody, catalog no. 70R-4348

Peptide H-LASAYGAR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LASAYGAR^-OH include the following: Reduced level of tear antimicrobial and immunomodulatory proteins as a possible reason for higher ocular infections in diabetic patients G Kallo , AK Varga, J Szabo, M Emri , J TÅ‘zser , A Csutak - Pathogens, 2021 - mdpi.comhttps://www.mdpi.com/2076-0817/10/7/883 Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers aca‰ CsÅ‘sz , P Labiscsak, G Kallo , B Markus , M Emri - PLoS , 2017 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0177282

Custom research peptide; min purity 95%.

Peptide H-NPDDPDTVDVIMHMLDR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NPDDPDTVDVIMHMLDR-OH include the following: Quantitation of peptides from non-invasive skin tapings using isotope dilution and tandem mass spectrometry N Reisdorph , M Armstrong, R Powell, K Quinn - of Chromatography B, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023217322158

A synthetic peptide for use as a blocking control in assays to test for specificity of PPAPDC2 antibody, catalog no. 70R-6944

Peptide H-EIWTFSTKV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-EIWTFSTKV-OH include the following: Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': an analysis of safety and immune response TJ Vreeland , JK Litton , NA Qiao, AV Philips - Clinical , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661617308653 Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients TA Brown, K Byrd, TJ Vreeland , GT Clifton - Cancer , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.2378 Peptides for diagnosis and treatment of ovarian cancer L Guo, J Wang, N Li, J Cui, Y Su - Frontiers in Oncology, 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2023.1135523/full Final Analysis of a Randomized Phase 1b Trial to Assess Sequencing of the E39 and E39'Vaccines to Optimize Long-Term Antitumor Immunity in Folate Binding K Peace, T Vreeland , JW Myers - Journal of the , 2017 - journals.lww.comhttps://journals.lww.com/journalacs/fulltext/2017/10001/final_analysis_of_a_randomized_phase_1b_trial_to.30.aspx Phase Ib Trial Comparing Different Doses and Schedules of a Folate-Binding Protein-Derived Peptide Vaccine, E39, and its Attenuated Version, E39', to Induce Long DO Jackson, T Vreeland , DF Hale - Journal of the , 2016 - journals.lww.comhttps://journals.lww.com/journalacs/fulltext/2016/10001/Phase_Ib_Trial_Comparing_Different_Doses_and.22.aspx Abstract P6-10-04: Determining the optimal vaccination strategy using a combination of the folate binding protein (FBP) peptide vaccine (E39+ GM-CSF) and an DO Jackson, N Qiao, KM Peace, DF Hale, TJ Vreeland - Cancer Research, 2017 - AACRhttps://aacrjournals.org/cancerres/article/77/4_Supplement/P6-10-04/624644 Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+ D Jackson, N Qiao, JM Greene, D Hale, J Berry - for ImmunoTherapy of , 2015 - Springerhttps://link.springer.com/article/10.1186/2051-1426-3-S2-P156

Peptide Ac-ASRMEEVD-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-ASRMEEVD-OH include the following: Binding properties of the quaternary assembly protein SPAG1 ME Chagot, R Dos Santos Morais - Biochemical , 2019 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/476/11/1679/219592 Insights into the conformational dynamics of the E3 ubiquitin ligase CHIP in complex with chaperones and E2 enzymes C Graf, M Stankiewicz, R Nikolay , MP Mayer - Biochemistry, 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi901829f

Peptide H-YSPITNF-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YSPITNF-NH2 include the following: Treatment efficacy of the lead RNAIII-inhibiting peptide YSPWTNF-NH2 in acquired Staphylococcus aureus sepsis: a histopathological assessment PD Ribeiro, OD Ribeiro, AM Marcolan - Peptides, 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978103003590 Using Phage Display to Select Peptides Binding to Type 5 capsular polysaccharide ofStaphylococcus aureus MN Maratani - 2017 - rave.ohiolink.eduhttps://rave.ohiolink.edu/etdc/view?acc_num=ysu1504010764721148

Peptide H-VHGLEIQGR-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VHGLEIQGR-OH include the following: Mitochondrial amidoxime-reducing component 1 p. Ala165Thr increases protein degradation mediated by the proteasome T Dutta , K Sasidharan , E Ciociola, G Pennisi - Liver , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/liv.15857

Peptide H-VDWENVSPEL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VDWENVSPEL-OH include the following: Adaptive nanoparticle platforms for high throughput expansion and detection of antigen-specific T cells JW Hickey , A Isser , SF Salathe , KM Gee, MH Hsiao - Nano , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.nanolett.0c01511

Peptide H-SSKGR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SSKGR^-OH include the following: A novel secreted protease from Pseudomonas aeruginosa activates NF-κB through protease-activated receptors Y Kida, Y Higashimoto , H Inoue, T Shimizu - Cellular , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1462-5822.2008.01142.x EprS, an autotransporter protein of Pseudomonas aeruginosa, possessing serine protease activity induces inflammatory responses through protease-activated Y Kida, J Taira, T Yamamoto - Cellular , 2013 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/cmi.12106 Mold allergen, pen C 13, induces IL-8 expression in human airway epithelial cells by activating protease-activated receptor 1 and 2 LL Chiu, DW Perng, CH Yu, SN Su - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/8/5237/74408 Proteolytic activity of Triatoma infestans saliva associated with PAR-2 activation and vasodilation KA Oliveira, RJS Torquato , DCGG Lustosa - Journal of Venomous , 2021 - SciELO Brasilhttps://www.scielo.br/j/jvatitd/a/wQMXjndrz56Sf5kxbDFMHGk/ Thrombin-mediated direct activation of proteinase-activated receptor-2: another target for thrombin signaling K Mihara, R Ramachandran , M Saifeddine - Molecular , 2016 - ASPEThttps://molpharm.aspetjournals.org/content/89/5/606.short Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells G Sun, MA Stacey, M Schmidt, L Mori - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/2/1014/33975 Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2 A Uehara, S Sugawara , K Muramoto - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/169/8/4594/35514 Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2 A Uehara, K Muramoto , H Takada - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/170/11/5690/71179

Peptide H-INFDFNTI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-INFDFNTI-OH include the following: Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model Y Akiyama, SM Caucheteux, C Vernochet - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/186/3/1442/85013 Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes N Auphan-Anezin, C Mazza - European journal of , 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200635895 T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and LK Iwai , MA Juliano , L Juliano , J Kalil - Journal of , 2005 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0896841105000077 Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes KM Armstrong, KH Piepenbrink - Biochemical Journal, 2008 - portlandpress.comhttps://portlandpress.com/biochemj/article-abstract/415/2/183/44453 Understanding the complexity and malleability of T-cell recognition JJ Miles , J McCluskey , J Rossjohn - Immunology and cell , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1038/icb.2014.112 CDR3 loop flexibility contributes to the degeneracy of TCR recognition JB Reiser, C Darnault, C Gregoire, T Mosser - Nature , 2003 - nature.comhttps://www.nature.com/articles/ni891 Crystal structure of a T cell receptor bound to an allogeneic MHC molecule JB Reiser, C Darnault, A Guimezanes, C Gregoire - Nature , 2000 - nature.comhttps://www.nature.com/articles/ni1000_291 The self-peptide repertoire plays a critical role in transplant tolerance induction ET Son, P Faridi , M Paul-Heng - The Journal of , 2021 - Am Soc Clin Investighttps://www.jci.org/articles/view/146771 MHC restriction and allogeneic immune responses DB Kazansky - Journal of immunotoxicology, 2008 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/15476910802476708 Minor histocompatibility antigens: presentation principles, recognition logic and the potential for a healing hand CT Spencer , P Gilchuk , SM Dragovic - Current opinion in organ , 2010 - journals.lww.comhttps://journals.lww.com/co-transplantation/fulltext/2010/08000/Minor_histocompatibility_antigens__presentation.00020.aspx Peptide-MHC-stability Determines the Size of the CD8+ T Cell Response Toward an Immunorecessive Tumor Antigen Determinant AM Watson - 2011 - etda.libraries.psu.eduhttps://etda.libraries.psu.edu/catalog/11971 The structural basis of T-cell allorecognition A Whitelegg, LD Barber - Tissue Antigens, 2004 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1399-0039.2004.00188.x Identification of endogenous peptides recognized by in vivo or in vitro generated alloreactive cytotoxic T lymphocytes: distinct characteristics correlated with CD8 A Guimezanes, GA Barrett-Wilt - European journal of , 2001 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200102)31:2%3C421::AID-IMMU421%3E3.0.CO;2-4 Structural and kinetic basis for low affinity cross-reactivity in T cell allorecognition A Guimezanes, F Montero-Julian - European journal of , 2003 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200324249

Catalogue peptide; min. 95% purity

A synthetic peptide for use as a blocking control in assays to test for specificity of PPM1J antibody, catalog no. 70R-3522

LHRH (1-5) (free acid) trifluoroacetate salt is a synthetic hormone that is used in the treatment of prostate cancer. It inhibits the release of luteinizing hormone and follicle-stimulating hormone from the anterior pituitary gland, which suppresses testosterone production by the testes. LHRH (1-5) (free acid) trifluoroacetate salt is synthesized industrially using a liquid phase synthesis. The product may be recycled by returning it to the manufacturing process or using it as an additive for plastics or other industrial products. LHRH (1-5) (free acid) trifluoroacetate salt was shown to be active against tumor cells in culture and inhibited cell growth in culture. This drug has been shown to inhibit the production of nitric oxide, which may contribute to its anti-tumor activity. LHRH (1-5) (free acid)

Peptide H-NLQEINAYIGHSVEK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NLQEINAYIGHSVEK-OH include the following: Peroxynitrite inactivation of human cytochrome P450s 2B6 and 2E1: heme modification and site-specific nitrotyrosine formation H Lin , E Myshkin, L Waskell - Chemical research in , 2007 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/tx700220e

Peptide H-SDVYCEVCEFLVK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SDVYCEVCEFLVK-OH include the following: Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease A Andersson, J Remnestaca¥l, B Nellgaca¥rd, H Vunk - Clinica Chimica , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0009898119303481

Viloxazine is a selective inhibitor for norepinephrine uptake over serotonin (5-HT) uptake in rat hypothalamic synaptosomes. It has been studied for its potential uses in treating attention-deficit hyperactivity disorder (ADHD) and depression.Viloxazine hydrochloride is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.

broad spectrum antibiotic

A synthetic peptide for use as a blocking control in assays to test for specificity of Esrrg antibody, catalog no. 70R-7908

Peptide Ac-CKGGAKL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-CKGGAKL-OH include the following: Peptide-based target-ing of fluorophores to organelles in living cells. KWA Wirtz - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=fe455113a311f70c60b5676ab745e006c07e6420 Peptide-based targeting of fluorophores to organelles in living cells EHW Pap, TB Dansen , R van Summeren - Experimental cell , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014482701951900

Cyclorasin 9A5 is a small molecule that inhibits the enzyme activity of protein kinase C (PKC). Cyclorasin 9A5 induces apoptosis by activating caspases in cancer cells. This peptide is also a potent inhibitor of PKC, which may be responsible for its anti-cancer effects. Cyclorasin 9A5 has been shown to inhibit the growth of cancer cells in vitro and in vivo. It also activates caspases, which are enzymes that break down proteins and other cellular components during apoptotic cell death. Cyclorasin 9A5 is thought to have potential as an anti-cancer drug due to its ability to inhibit PKC and activate caspases, as well as its low toxicity profile.

A synthetic peptide for use as a blocking control in assays to test for specificity of GPX4 antibody, catalog no. 70R-2447

Peptide Ac-ADADADADARARARAR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-ADADADADARARARAR-NH2 include the following: High-Throughput Screening of pH-Dependent beta-sheet Self-Assembling Peptide XW Ye, W Tian, L Han, YJ Li, S Liu, WJ Lai, YX Liu - Small, 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/smll.202307963